Rare disease: industry, patients and tech join forces on diagnosisTakeda’s Adam Zaeske discusses how cross-sector collaboration is shaping a brighter future for rare disease diagnosis. Diagnosis can Share XRare disease: industry, patients and tech join forces on diagnosishttps://pharmaphorum.com/views-and-analysis/rare-disease-industry-patients-and-tech-join-forces-on-the-diagnostic-odyssey/
Accelerating the adoption of innovation in the NHSSpreading innovation in the NHS is as much about fostering collaboration and building relationships as it is about Share XAccelerating the adoption of innovation in the NHShttps://pharmaphorum.com/views-and-analysis/accelerating-the-adoption-of-innovation-in-the-nhs/
A life sciences vision to deliver health, wealth and resilience for the UKThe ABPI’s chief executive Dr Richard Torbett outlines a new ‘vision’ and 10-year strategy for UK life sciences, Share XA life sciences vision to deliver health, wealth and resilience for the UKhttps://pharmaphorum.com/views-and-analysis/a-life-sciences-vision-to-deliver-health-wealth-and-resilience-for-the-uk/
COVID-19 neutralising antibody tests – an integrated approachNina Garrett, R&D director at Abingdon Health discusses the key role antibody testing is playing in the pandemic Share XCOVID-19 neutralising antibody tests – an integrated approachhttps://pharmaphorum.com/views-and-analysis/covid-19-antibody-tests-integrated-approach/
Herd immunity is nice – but what about me?Shahrokh Shabahang discusses why we need a personalised approach to COVID-19 immunity testing. To-date, the battle against COVID-19 Share XHerd immunity is nice – but what about me?https://pharmaphorum.com/views-and-analysis/herd-immunity-is-nice-but-what-about-me/
When biotech meets reality TV – Starton Therapeutics faces the Unicorn HuntersStarton Therapeutics is bypassing the traditional venture capital route to raise money for its transdermal delivery technology that Share XWhen biotech meets reality TV – Starton Therapeutics faces the Unicorn Huntershttps://pharmaphorum.com/views-and-analysis/when-biotech-meets-reality-tv/
Health Innovators: Eliot Forster, F-StarIn this episode of Health Innovators, pharmaphorum founder Paul Tunnah interviews Eliot Forster, CEO of F-Star – a clinical-stage, Share XHealth Innovators: Eliot Forster, F-Starhttps://pharmaphorum.com/views-analysis-oncology/health-innovators-eliot-forster-f-star/
Pharma’s use of synthetic biology could deliver radical innovationSynthetic biology holds much promise for the life sciences sector as it continues to look for new ways Share XPharma’s use of synthetic biology could deliver radical innovationhttps://pharmaphorum.com/r-d/pharma-synthetic-biology-radical-innovation/
COVID-19 vaccine development: Safety monitoring continues revolution in RWDFrom cancer to COVID, real-world data is changing the way we research therapeutics, monitor safety, and collaborate on Share XCOVID-19 vaccine development: Safety monitoring continues revolution in RWDhttps://pharmaphorum.com/r-d/covid-19-vaccine-development-safety-monitoring-continue-the-revolution-in-real-world-data/
